Bioresorbable scaffolds for percutaneous coronary interventions.

Area of Science:

• Cardiovascular Medicine
• Biomaterials Science
• Interventional Cardiology

Background:

• Drug-eluting stents (DES) have improved percutaneous coronary interventions (PCI) but permanent metallic implants can cause late complications.
• Limitations of current DES include sustained inflammation, neo-atherosclerosis, and impaired vasomotor function.
• The need for improved coronary implants drives innovation beyond traditional cobalt chromium, platinum chromium, or stainless steel.

Purpose of the Study:

• To provide a comprehensive overview of bioresorbable scaffold technology in coronary stenting.
• To elaborate on the potential benefits of transient coronary scaffolds over permanent stents.
• To discuss the challenges bioresorbable scaffolds face in competing with current DES.

Main Methods:

• Review of current literature on bioresorbable scaffolds and drug-eluting stents.
• Analysis of preliminary clinical data on the safety and efficacy of bioresorbable scaffolds.
• Discussion of material innovations and device design in coronary implants.

Main Results:

• Bioresorbable scaffolds, made from biodegradable polymers or biocorrodible metals, offer transient vessel scaffolding.
• These scaffolds provide local drug-elution and aim for future restoration of vessel anatomy and function.
• Preliminary evidence indicates comparable safety and intermediate-term clinical outcomes to current generation DES.

Conclusions:

• Bioresorbable scaffolds represent an iterative innovation in coronary implant materials.
• These devices have the potential for vascular reparation therapy by transiently supporting the vessel.
• Further development is needed for bioresorbable scaffolds to overcome challenges and compete effectively with current DES.